Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19

SARS-CoV-2 infection can cause severe respiratory COVID-19. However, many individuals present with isolated upper respiratory symptoms, suggesting potential to constrain viral pathology to the nasopharynx. Which cells SARS-CoV-2 primarily targets and how infection influences the respiratory epitheli...

Full description

Bibliographic Details
Main Authors: Ziegler, Carly, Miao, Vincent N., Owings, Anna H., Navia, Andrew W., Tang, Ying, Bromley, Joshua D., Lotfy, Peter, Sloan, Meredith, Laird, Hannah, Williams, Haley B., George, Micayla, Drake, Riley S., Christian, Taylor, Parker, Adam, Sindel, Campbell B., Burger, Molly W., Pride, Yilianys, Hasan, Mohammad, Abraham, George E., Senitko, Michal, Robinson, Tanya O., Shalek, Alexander K, Glover, Sarah C., Horwitz, Bruce H., Ordovas-Montanes, Jose
Other Authors: Harvard University--MIT Division of Health Sciences and Technology
Format: Article
Published: Elsevier BV 2021
Online Access:https://hdl.handle.net/1721.1/131202
_version_ 1826207314276777984
author Ziegler, Carly
Miao, Vincent N.
Owings, Anna H.
Navia, Andrew W.
Tang, Ying
Bromley, Joshua D.
Lotfy, Peter
Sloan, Meredith
Laird, Hannah
Williams, Haley B.
George, Micayla
Drake, Riley S.
Christian, Taylor
Parker, Adam
Sindel, Campbell B.
Burger, Molly W.
Pride, Yilianys
Hasan, Mohammad
Abraham, George E.
Senitko, Michal
Robinson, Tanya O.
Shalek, Alexander K
Glover, Sarah C.
Horwitz, Bruce H.
Ordovas-Montanes, Jose
author2 Harvard University--MIT Division of Health Sciences and Technology
author_facet Harvard University--MIT Division of Health Sciences and Technology
Ziegler, Carly
Miao, Vincent N.
Owings, Anna H.
Navia, Andrew W.
Tang, Ying
Bromley, Joshua D.
Lotfy, Peter
Sloan, Meredith
Laird, Hannah
Williams, Haley B.
George, Micayla
Drake, Riley S.
Christian, Taylor
Parker, Adam
Sindel, Campbell B.
Burger, Molly W.
Pride, Yilianys
Hasan, Mohammad
Abraham, George E.
Senitko, Michal
Robinson, Tanya O.
Shalek, Alexander K
Glover, Sarah C.
Horwitz, Bruce H.
Ordovas-Montanes, Jose
author_sort Ziegler, Carly
collection MIT
description SARS-CoV-2 infection can cause severe respiratory COVID-19. However, many individuals present with isolated upper respiratory symptoms, suggesting potential to constrain viral pathology to the nasopharynx. Which cells SARS-CoV-2 primarily targets and how infection influences the respiratory epithelium remains incompletely understood. We performed scRNA-seq on nasopharyngeal swabs from 58 healthy and COVID-19 participants. During COVID-19, we observe expansion of secretory, loss of ciliated, and epithelial cell repopulation via deuterosomal cell expansion. In mild and moderate COVID-19, epithelial cells express anti-viral/interferon-responsive genes, while cells in severe COVID-19 have muted anti-viral responses despite equivalent viral loads. SARS-CoV-2 RNA+ host-target cells are highly heterogenous, including developing ciliated, interferon-responsive ciliated, AZGP1high goblet, and KRT13+ “hillock”-like cells, and we identify genes associated with susceptibility, resistance, or infection response. Our study defines protective and detrimental responses to SARS-CoV-2, the direct viral targets of infection, and suggests that failed nasal epithelial anti-viral immunity may underlie and precede severe COVID-19.
first_indexed 2024-09-23T13:47:45Z
format Article
id mit-1721.1/131202
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T13:47:45Z
publishDate 2021
publisher Elsevier BV
record_format dspace
spelling mit-1721.1/1312022022-10-01T17:11:40Z Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19 Ziegler, Carly Miao, Vincent N. Owings, Anna H. Navia, Andrew W. Tang, Ying Bromley, Joshua D. Lotfy, Peter Sloan, Meredith Laird, Hannah Williams, Haley B. George, Micayla Drake, Riley S. Christian, Taylor Parker, Adam Sindel, Campbell B. Burger, Molly W. Pride, Yilianys Hasan, Mohammad Abraham, George E. Senitko, Michal Robinson, Tanya O. Shalek, Alexander K Glover, Sarah C. Horwitz, Bruce H. Ordovas-Montanes, Jose Harvard University--MIT Division of Health Sciences and Technology Massachusetts Institute of Technology. Institute for Medical Engineering & Science Massachusetts Institute of Technology. Department of Chemistry Massachusetts Institute of Technology. Microbiology Graduate Program Koch Institute for Integrative Cancer Research at MIT SARS-CoV-2 infection can cause severe respiratory COVID-19. However, many individuals present with isolated upper respiratory symptoms, suggesting potential to constrain viral pathology to the nasopharynx. Which cells SARS-CoV-2 primarily targets and how infection influences the respiratory epithelium remains incompletely understood. We performed scRNA-seq on nasopharyngeal swabs from 58 healthy and COVID-19 participants. During COVID-19, we observe expansion of secretory, loss of ciliated, and epithelial cell repopulation via deuterosomal cell expansion. In mild and moderate COVID-19, epithelial cells express anti-viral/interferon-responsive genes, while cells in severe COVID-19 have muted anti-viral responses despite equivalent viral loads. SARS-CoV-2 RNA+ host-target cells are highly heterogenous, including developing ciliated, interferon-responsive ciliated, AZGP1high goblet, and KRT13+ “hillock”-like cells, and we identify genes associated with susceptibility, resistance, or infection response. Our study defines protective and detrimental responses to SARS-CoV-2, the direct viral targets of infection, and suggests that failed nasal epithelial anti-viral immunity may underlie and precede severe COVID-19. 2021-08-25T16:25:18Z 2021-08-25T16:25:18Z 2021-07 2021-05 Article http://purl.org/eprint/type/JournalArticle 0092-8674 https://hdl.handle.net/1721.1/131202 Ziegler, Carly G.K. et al. "Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19." Cell (July 2021): 10.1016/j.cell.2021.07.023. © 2021 The Authors https://dx.doi.org/10.1016/j.cell.2021.07.023 Cell Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Elsevier BV Elsevier
spellingShingle Ziegler, Carly
Miao, Vincent N.
Owings, Anna H.
Navia, Andrew W.
Tang, Ying
Bromley, Joshua D.
Lotfy, Peter
Sloan, Meredith
Laird, Hannah
Williams, Haley B.
George, Micayla
Drake, Riley S.
Christian, Taylor
Parker, Adam
Sindel, Campbell B.
Burger, Molly W.
Pride, Yilianys
Hasan, Mohammad
Abraham, George E.
Senitko, Michal
Robinson, Tanya O.
Shalek, Alexander K
Glover, Sarah C.
Horwitz, Bruce H.
Ordovas-Montanes, Jose
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
title Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
title_full Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
title_fullStr Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
title_full_unstemmed Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
title_short Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
title_sort impaired local intrinsic immunity to sars cov 2 infection in severe covid 19
url https://hdl.handle.net/1721.1/131202
work_keys_str_mv AT zieglercarly impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT miaovincentn impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT owingsannah impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT naviaandreww impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT tangying impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT bromleyjoshuad impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT lotfypeter impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT sloanmeredith impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT lairdhannah impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT williamshaleyb impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT georgemicayla impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT drakerileys impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT christiantaylor impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT parkeradam impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT sindelcampbellb impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT burgermollyw impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT prideyilianys impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT hasanmohammad impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT abrahamgeorgee impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT senitkomichal impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT robinsontanyao impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT shalekalexanderk impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT gloversarahc impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT horwitzbruceh impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19
AT ordovasmontanesjose impairedlocalintrinsicimmunitytosarscov2infectioninseverecovid19